Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Program symbols : Nvs save search
Multiple Sclerosis Patients in US Left Without Essential Patient Support Program Will Now Receive Equivalent Backing From Cycle Pharmaceuticals Following FDA’s Approval of TASCENSO ODT® (fingolimod)
Published: 2023-01-17 (Crawled : 19:00) - biospace.com/
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 2.34%
H: 0.04%
C: -0.87%
odt pharmaceuticals program approval sclerosis
Voyager Therapeutics Announces License Option Agreement with Novartis for Target-Specific Access to Next-Generation TRACER™ AAV Capsids for Gene Therapy Programs
Published: 2022-03-08 (Crawled : 07:00) - globenewswire.com
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -4.98%
H: 0.0%
C: 0.0%
VYGR | $7.5 -0.66% -0.67% 520K
|
Health Technology
|
| O: 31.15%
H: 19.58%
C: 9.17%
trace novartis aav capsids gene therapy program license therapeutics therapy
Sarcoma Therapeutics Market 2022-2026 | Patient Assistance Programs to Boost Growth | Technavio
Published: 2022-02-28 (Crawled : 11:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: -3.4%
H: 7.54%
C: 7.54%
CYTR | $0.092
|
Manufacturing
|
| O: 0.0%
H: 0.0%
C: -3.12%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.5%
H: 0.0%
C: 0.0%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -0.21%
H: 0.0%
C: 0.0%
KPTI | $1.16 -9.38% -10.34% 1.4M
|
Health Technology
|
| O: 0.1%
H: 0.1%
C: -1.62%
AGEN | $5.3 6.64% 6.23% 1.5M
|
Health Technology
|
| O: -1.31%
H: 0.0%
C: 0.0%
ADAP | $0.97 7.97% 7.38% 1.5M
|
Health Technology
|
| O: -1.86%
H: 4.92%
C: -1.52%
program therapeutics growth
Transactions in connection with share buy-back program
Published: 2021-05-10 (Crawled : 08:00) - globenewswire.com
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.05%
H: 0.37%
C: -0.02%
GMAB | $28.72 1.38% 1.36% 360K
|
Health Technology
|
| O: 0.48%
H: 0.4%
C: -0.9%
program
Transactions in connection with share buy-back program
Published: 2021-05-03 (Crawled : 08:00) - globenewswire.com
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 1.15%
H: 0.32%
C: 0.2%
GMAB | $28.72 1.38% 1.36% 360K
|
Health Technology
|
| O: -0.35%
H: 0.16%
C: -1.36%
program
Transactions in connection with share buy-back program
Published: 2021-04-19 (Crawled : 08:00) - globenewswire.com
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.53%
H: 0.09%
C: -0.12%
GMAB | $28.72 1.38% 1.36% 360K
|
Health Technology
|
| O: 1.05%
H: 0.31%
C: -0.03%
program
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.